Investigation on Safety, Tolerability, and Pharmacokinetics of Single Doses of NNC0113-0987 in Healthy Male Subjects
Status:
Completed
Trial end date:
2012-12-11
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to investigate safety,
tolerability and pharmacokinetics (the exposure of the trial drug in the body) of single
doses of NNC0113-0987 in healthy male subjects.